Rapafusyn Pharmaceuticals
PrivateLast Round
Series A
Sep 4, 2025
Total Funding Raised
$44M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Rapafusyn Pharmaceuticals operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Series A round in September 2025.
Rapafusyn Pharmaceuticals is a biotechnology company that develops non-degrading molecular glues (RapaGlues™) to address challenging therapeutic targets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rapafusyn Pharmaceuticals Comparables
Compare Rapafusyn Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Magnet Biomedicine | 88% | |
| Plexium | 87% | |
| Orionis Biosciences | 86% |
For institutional investors. Book with your work email.
Rapafusyn Pharmaceuticals Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Rapafusyn Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series A |
| Bencao Capital | Series A |
| Yonjin Capital | Series A |
| Lapam Capital | Series A |
| Proxima Ventures Ltd. | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 41% MoM.
- Sep 4, 2025
$44M round completed.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 2, 2026
Rapafusyn is scheduled to present a company overview at the H.C. Wainwright 28th Annual Global Investment Conference in New York on Sep 14th-15th '26, with President and CEO Dr. Sean Hu delivering the presentation.
For institutional investors. Book with your work email.
Rapafusyn Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rapafusyn Pharmaceuticals's valuation, stock price, and market status.
Is Rapafusyn Pharmaceuticals a public or private company?
Rapafusyn Pharmaceuticals is a private company.
What is the current stock price of Rapafusyn Pharmaceuticals?
Rapafusyn Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Rapafusyn Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rapafusyn Pharmaceuticals worth (valuation)?
Valuation information for Rapafusyn Pharmaceuticals is not publicly available.
Can I buy Rapafusyn Pharmaceuticals stock?
Rapafusyn Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rapafusyn Pharmaceuticals's last funding round?
Rapafusyn Pharmaceuticals's most recent funding round was Series A on September 4, 2025.
Who are the main investors in Rapafusyn Pharmaceuticals?
Key investors in Rapafusyn Pharmaceuticals include BioTrack Capital, Yonjin Capital.
Will Rapafusyn Pharmaceuticals IPO soon?
No public IPO plans have been announced for Rapafusyn Pharmaceuticals.
How can I track Rapafusyn Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Rapafusyn Pharmaceuticals's shares on secondary markets.